L-T. Chen

1.2k total citations
47 papers, 906 citations indexed

About

L-T. Chen is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, L-T. Chen has authored 47 papers receiving a total of 906 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Surgery, 16 papers in Oncology and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in L-T. Chen's work include Gastric Cancer Management and Outcomes (10 papers), Pancreatic and Hepatic Oncology Research (7 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers). L-T. Chen is often cited by papers focused on Gastric Cancer Management and Outcomes (10 papers), Pancreatic and Hepatic Oncology Research (7 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers). L-T. Chen collaborates with scholars based in Taiwan, United States and South Korea. L-T. Chen's co-authors include Yu‐Wen Hsu, Leonard Weiss, L. Weiss, Andrew H. Ko, Wu‐Chou Su, A. Ong, Margaret A. Tempero, Yulin Lin, Chen‐Hao Yeh and Elizabeth Dito and has published in prestigious journals such as Science, Blood and Oncogene.

In The Last Decade

L-T. Chen

44 papers receiving 891 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
L-T. Chen Taiwan	17	299	252	238	233	203	47	906
Regine Dahse Germany	17	227 0.8×	353 1.4×	99 0.4×	225 1.0×	174 0.9×	47	870
J W Shay Japan	9	454 1.5×	577 2.3×	146 0.6×	145 0.6×	123 0.6×	10	1.3k
Ryuichi Denno Japan	16	276 0.9×	215 0.9×	141 0.6×	213 0.9×	105 0.5×	46	673
Izhar Bagwan United Kingdom	15	352 1.2×	301 1.2×	194 0.8×	211 0.9×	237 1.2×	59	884
Steve Gyorffy Canada	14	258 0.9×	242 1.0×	220 0.9×	146 0.6×	96 0.5×	18	798
Antonella De Stefani Italy	18	436 1.5×	315 1.3×	223 0.9×	250 1.1×	98 0.5×	37	1.2k
V-M Kosma Finland	18	387 1.3×	553 2.2×	165 0.7×	101 0.4×	183 0.9×	20	1.1k
A Rejthar Czechia	8	421 1.4×	305 1.2×	80 0.3×	104 0.4×	116 0.6×	32	789
Hannelore Schmidt Germany	20	490 1.6×	619 2.5×	396 1.7×	99 0.4×	176 0.9×	53	1.2k
Andre L. Reed United States	8	505 1.7×	613 2.4×	114 0.5×	178 0.8×	186 0.9×	11	1.0k

Countries citing papers authored by L-T. Chen

Since Specialization

Citations

This map shows the geographic impact of L-T. Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L-T. Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L-T. Chen more than expected).

Fields of papers citing papers by L-T. Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L-T. Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L-T. Chen. The network helps show where L-T. Chen may publish in the future.

Co-authorship network of co-authors of L-T. Chen

This figure shows the co-authorship network connecting the top 25 collaborators of L-T. Chen. A scholar is included among the top collaborators of L-T. Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L-T. Chen. L-T. Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

He, Aiwu Ruth, Shukui Qin, L-T. Chen, et al.. (2024). 55P Subsequent anticancer therapy (SAT) analysis from 3-year follow-up of the phase III TOPAZ-1 study of durvalumab plus gemcitabine and cisplatin in biliary tract cancer (BTC). Annals of Oncology. 35. S233–S234.

Garmezy, Benjamin, Mitesh J. Borad, L-T. Chen, et al.. (2023). 130P Phase I study evaluating KIN-3248, a next-generation, irreversible pan-FGFR inhibitor, in patients with advanced cholangiocarcinoma, urothelial carcinoma and other solid tumors harboring FGFR2 and/or FGFR3 gene alterations. Annals of Oncology. 34. S231–S232. 1 indexed citations

Chen, L-T., et al.. (2022). 78P Updated overall survival (OS) from the phase III TOPAZ-1 study of durvalumab (D) or placebo (PBO) plus gemcitabine and cisplatin (+ GC) in patients (pts) with advanced biliary tract cancer (BTC). Annals of Oncology. 33. S1462–S1463. 18 indexed citations

Chen, L-T., et al.. (2022). 261MO Real-world data on prevalence of MSI-H/dMMR across 6 solid tumor types in Asia. Annals of Oncology. 33. S1535–S1535.

Chen, L-T., et al.. (2022). 101P Real-world prevalence of MSI-H/dMMR across 6 different tumor types in Asia. Annals of Oncology. 33. S585–S585. 1 indexed citations

Oh, D-Y., et al.. (2022). 56P Updated overall survival (OS) from the phase III TOPAZ-1 study of durvalumab (D) or placebo (PBO) plus gemcitabine and cisplatin (+ GC) in patients (pts) with advanced biliary tract cancer (BTC). Annals of Oncology. 33. S565–S566. 19 indexed citations

Boku, Narikazu, M.-H. Ryu, D-Y. Oh, et al.. (2020). LBA7_PR Nivolumab plus chemotherapy versus chemotherapy alone in patients with previously untreated advanced or recurrent gastric/gastroesophageal junction (G/GEJ) cancer: ATTRACTION-4 (ONO-4538-37) study. Annals of Oncology. 31. S1192–S1192. 80 indexed citations

Kang, Y-K., Ken Kato, Hyun Cheol Chung, et al.. (2017). Interim safety and clinical activity of nivolumab (Nivo) in combination with S-1/capecitabine plus oxaliplatin in patients (pts) with previously untreated unresectable advanced or recurrent gastric/gastroesophageal junction (G/GEJ) cancer: part 1 study of ATTRACTION-04 (ONO-4538-37). Annals of Oncology. 28. v228–v229. 5 indexed citations

Chen, L-T., et al.. (2017). ATTRACTION-04 (ONO-4538-37): A randomized, multicenter, phase 2/3 study of nivolumab (Nivo) plus chemotherapy in patients (Pts) with previously untreated advanced or recurrent gastric (G) or gastroesophageal junction (GEJ) cancer. Annals of Oncology. 28. v266–v266. 9 indexed citations

10.

Boku, Narikazu, Y-K. Kang, Taroh Satoh, et al.. (2017). A Phase 3 Study of nivolumab (Nivo) in previously treated advanced gastric or gastroesophageal junction (G/GEJ) cancer: Updated results and subset analysis by PD-L1 expression (ATTRACTION-02). Annals of Oncology. 28. v209–v209. 20 indexed citations

11.

Hubner, Richard, L-T. Chen, Li Cp, et al.. (2017). Prognostic value of baseline neutrophil-to-lymphocyte ratio for predicting clinical outcome in metastatic pancreatic ductal adenocarcinoma (mPDAC) patients treated with liposomal irinotecan (nal-IRI) + 5-fluorouracil and leucovorin (5-FU/LV) vs 5-FU/LV alone. Annals of Oncology. 28. v253–v253. 1 indexed citations

12.

Liao, Fang, Yi‐Chiang Hsu, Sung‐Hsin Kuo, et al.. (2014). Genetic polymorphisms and tissue expression of interleukin-22 associated with risk and therapeutic response of gastric mucosa-associated lymphoid tissue lymphoma. Blood Cancer Journal. 4(10). XX–XX. 25 indexed citations

13.

Ko, Andrew H., Margaret A. Tempero, Wu‐Chou Su, et al.. (2013). A multinational phase 2 study of nanoliposomal irinotecan sucrosofate (PEP02, MM-398) for patients with gemcitabine-refractory metastatic pancreatic cancer. British Journal of Cancer. 109(4). 920–925. 126 indexed citations

14.

Yang, TS, Yee Chao, C-C. Lin, et al.. (2010). A randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patients. British Journal of Cancer. 103(7). 954–960. 131 indexed citations

15.

Chen, L-T., et al.. (2000). Demographic transition and social security in Taiwan.. Population and Development Review. 4 indexed citations

16.

Chen, L-T., et al.. (1999). Design Charts for Analysis of Piles Subjected to Lateral Soil Movements. 367. 2 indexed citations

17.

Chen, L-T., et al.. (1996). Some Aspects of Pile Response Near an Excavation. 604. 6 indexed citations

18.

Chen, L-T., et al.. (1995). Variable tissue reactions and endocrine responses to a jugular catheter.. PubMed. 27(1). 83–9. 5 indexed citations

19.

Chen, L-T. & Ursula Scheffel. (1977). Blood flow and phagocytic activity of the spleen of the rat with acute hemolytic anemia.. PubMed. 22(6). 507–21. 7 indexed citations

20.

Chen, L-T., et al.. (1962). PALMAR DERMATOGLYPHICS IN THE VATAAN AMI, TAIWAN.. PubMed. 61. 853–67. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact